BackGRI Bio Overview

GRI Bio Receivables

GRI Bio's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average

Loading

GRI Bio Receivables History

Loading

GRI Bio vs. peers: Receivables Comparison

Loading

GRI Bio Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GRI Bio (GRI) FAQ

The latest receivables for GRI is $0 as of January 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside GRI Bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, GRI's receivables moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GRI Bio's operating scale or balance-sheet position.

A receivables figure of $0 for GRI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GRI's receivables ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack GRI Bio's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.